Compare Grab Holdings Ltd. (GRAB) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Grab Holdings Ltd. vs GeneDx Holdings Corp — how do they compare? Grab Holdings Ltd. trades at $3.63 (market cap $15.26B), while GeneDx Holdings Corp trades at $82.69 (market cap $2.44B). The key difference: Grab Holdings Ltd. is far larger — about 6.3× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Grab Holdings Ltd. nearer its low. Which is the better fit depends on your goals.
| GRAB | WGS | |
|---|---|---|
Market Cap | $15.26B | $2.44B |
Sector | Technology | Technology |
52-Week High | $6.45 | $167.51 |
52-Week Low | $3.27 | $34.51 |
Enterprise Value | $10.99B | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GRAB trades at $3.67, up 0.27% today, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. Revenue grew to $3.37B in 2025, with net income turning positive at $268M, reflecting improved profitability. The company raised its 2026 guidance after Q2 results, driven by on-demand and financial services growth. Analyst consensus is strongly bullish with an average price target of $5.86, implying 58% upside.
The outlook is positive given consistent earnings outperformance and raised guidance, but risks include high valuation (P/E 34), insider selling, and projected negative cash flow in 2026. Investors should weigh growth momentum against execution challenges in competitive Southeast Asian markets.
GeneDx Holdings Corp (WGS) trades at $82.36, up 5.75% in 24 hours, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS and record testing volumes, though net income margins remain negative. The stock faces class action litigation risks but benefits from institutional buying and new product launches.
Outlook is mixed: bullish technicals and 91% buy ratings suggest upside to the $90 high target, but negative profitability and legal overhangs pose risks. Investors should weigh growth potential against financial sustainability and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Grab Holdings Ltd.
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
